CN203468711U - Multifunctional intrauterine adhesion control and treatment unit - Google Patents
Multifunctional intrauterine adhesion control and treatment unit Download PDFInfo
- Publication number
- CN203468711U CN203468711U CN201320636158.9U CN201320636158U CN203468711U CN 203468711 U CN203468711 U CN 203468711U CN 201320636158 U CN201320636158 U CN 201320636158U CN 203468711 U CN203468711 U CN 203468711U
- Authority
- CN
- China
- Prior art keywords
- cavity
- check valve
- inner bag
- connecting duct
- expansion inner
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 208000028685 Asherman syndrome Diseases 0.000 title abstract description 18
- 201000001389 adhesions of uterus Diseases 0.000 title abstract description 18
- 210000004291 uterus Anatomy 0.000 claims abstract description 32
- 239000000463 material Substances 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 7
- 210000003679 cervix uteri Anatomy 0.000 claims description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 4
- 239000000741 silica gel Substances 0.000 claims description 4
- 229910002027 silica gel Inorganic materials 0.000 claims description 4
- 239000004816 latex Substances 0.000 claims description 3
- 229920000126 latex Polymers 0.000 claims description 3
- 241001149930 Protura <class> Species 0.000 claims description 2
- 239000003814 drug Substances 0.000 abstract description 8
- 230000023597 hemostasis Effects 0.000 abstract description 5
- 238000002955 isolation Methods 0.000 abstract description 4
- 239000011664 nicotinic acid Substances 0.000 abstract 1
- 230000002980 postoperative effect Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000002357 endometrial effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000000416 exudates and transudate Anatomy 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 241000459479 Capsula Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000002648 combination therapy Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 210000004696 endometrium Anatomy 0.000 description 1
- 230000001076 estrogenic effect Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 210000005077 saccule Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Images
Landscapes
- Media Introduction/Drainage Providing Device (AREA)
- Surgical Instruments (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
The utility model relates to a multifunctional intrauterine adhesion control and treatment unit which comprises a skeleton layer, an expansion inner container, a one-way valve, two connecting guide pipes, a pressure gauge, a dosing unit and a pressure injector. The skeleton layer is of a bionic uterus structure. The expansion inner container is arranged on the inner side of the skeleton layer. The skeleton layer joins the opening of the expansion inner container to form a double cavity structure, and the two cavities are both connected with the one-way valve. One end of each connecting guide pipe is connected with the one-way valve, the other end of one connecting guide pipe is connected with the dosing unit, and the other end of the other connecting guide pipe is connected with the pressure injector. The two connecting guide pipes are communicated with a cavity between the expansion inner container and the skeleton layer and a cavity in the expansion inner container through two valve ports of the one-way valve respectively. Through the multifunctional intrauterine adhesion control and treatment unit, intrauterine operation integrated management integrating the functions of post-operation wound hemostasis, nidus isolation, a medicine delivery passage and other functions can be achieved, and various routes capable of causing intrauterine adhesion can be completely blocked after an intrauterine operation.
Description
Technical field
This utility model relates to a kind of multi-function uterus cavity adhesion control device, belongs to medical apparatus and instruments material utensil field.
Background technology
Any factor that causes that endometrium is destroyed all can cause metrosynizesis, intrauterine adhesion and PAly account for 91%; Be common in after artificial abortion or the spontaneous abortion dilatation and curettage.The intrauterine adhesion that non-gestation causes accounts for 9%, as endometrial tuberculosis, myomectomy, Curettage etc.
The sickness rate of intrauterine adhesion accounts for the 30-40% of all uteroventral operation classes operation, and intrauterine adhesion can cause the minimizing of patient's menstrual blood volume, amenorrhea, infertile etc., and it has a strong impact on women's at reproduction age healthy and healthy reproduction.
The research of the cause of disease, diagnosis and the control etc. that occur for intrauterine adhesion, obtains numerous focus of attentions.The method of preventing and treating both domestic and external to intrauterine adhesion is also more, mainly contains postoperative placement intrauterine device in earlier stage, places barrier, places saccule urinary catheter, estrogenic therapy etc., although these measures are effective, clinical practice effect is also desirable not to the utmost.And be only confined to the prevention of the intrauterine adhesion after the separation of serious symptom intrauterine adhesion.After uteroventral operation operation, prevention intrauterine adhesion mainly consider following some, whether hemostasis is abundant, prevention, the healing rate of damage, the isolation barrier of wound surface etc. of infection, high incidence in view of intrauterine adhesion after the operation of uteroventral operation class, be necessary to take prophylactico-therapeutic measures after uteroventral operation operation, as the postoperative integrated management of uteroventral operation, the generation of blocking-up intrauterine adhesion.
Utility model content
Technical problem to be solved in the utility model is to provide a kind of multi-function uterus cavity adhesion control device.
The technical scheme that this utility model solves the problems of the technologies described above is as follows: a kind of multi-function uterus cavity adhesion control device, comprise casing play, expansion inner bag, and check valve, connecting duct, Pressure gauge, administrator, pressure injector,
Described casing play is shaped as bionical uterus structure, is provided with administration channel and has the first opening on it, and described the first opening is connected with described check valve;
Described expansion inner bag is arranged on described casing play inner side, has the second opening, and described the second opening is connected with described check valve;
Described check valve has the first valve port and the second valve port, and described the first valve port is communicated with the cavity between described casing play with described expansion inner bag; Described the second valve port is communicated with the cavity in described expansion inner bag;
Described connecting duct comprises the first connecting duct and the second connecting duct, one end of described the first connecting duct and the second connecting duct all removably connects with described check valve, described the first connecting duct is communicated with the cavity between described casing play with described expansion inner bag by described check valve, and described the second connection tube is communicated with the cavity in described expansion inner bag by described check valve;
Described Pressure gauge is arranged on described the second connecting duct and with it and is communicated with; Described administrator and the described first connecting duct other end removably connect; Described pressure injector and the second connecting duct other end removably connect.
The beneficial effects of the utility model are: this device can be realized multi-functional uteroventral operation integrated managemenies such as integrating postoperative wound surface hemostasis, focus isolation, medicine enforcement passage, and this is installed on after uteroventral operation operation, blocks the various approach that intrauterine adhesion occurs comprehensively.
On the basis of technique scheme, this utility model can also be done following improvement.
Further, described administrator is the syringe of Rule conehead.
Further, described administration channel is 10～50, and its diameter is 0.5mm～3mm, preferably 1mm～2mm.Be used for effectively for discharging medicine.
Further, described administration channel is arranged on a place or any a few place of Jiao,Gong edge, palace, top, palace and the cervix uteri of casing play.The uterus of human body is slightly like the slightly flat inversion pyriform in front and back.It can be divided into three parts: the part of upper end boss is fundus of uterus: the part that lower end is narrow is cervix uteri; Major part between the end and neck is body of uterus.The inner chamber in uterus is very narrow, is sub-official jargon.Casing play is shaped as bionical uterus structure, its at Jiao,Gong edge, palace, palace top and cervix uteri etc. easily stick together out administration channel are set, and can better discharge medicine, prevent that adhesion from occurring.
Further, casing play is silica gel material.Silica gel material has the good function of biocompatibility of anti-expansion, softness, effectively protects uterus.
Further, described expansion inner bag is latex material.
Further, the external inner-rotary type interface of described check valve.
Further, the built-in spring top stop type of described check valve valve.
Further, also comprise thimble, described thimble, for jack-up administration check valve, discharges the medicinal liquid of the cavity between described expansion inner bag and described casing play and the liquid in the cavity in described expansion inner bag.
Accompanying drawing explanation
Fig. 1 is a kind of multi-function uterus cavity adhesion control of this utility model apparatus structure schematic diagram;
Fig. 2 is the structural representation that a kind of multi-function uterus cavity adhesion of this utility model prevents and treats the thimble adopting in device.
In accompanying drawing, the list of parts of each label representative is as follows:
1, casing play, 2, expansion inner bag, 3, check valve, 4, connecting duct, 5, Pressure gauge, 6, administrator, 7, pressure injector, 8, the cavity between expansion inner bag and described casing play, 9, the cavity in expansion inner bag, 10, administration channel, 11, thimble.
The specific embodiment
Below in conjunction with accompanying drawing, principle of the present utility model and feature are described, example, only for explaining this utility model, is not intended to limit scope of the present utility model.
As shown in Figure 1, a kind of multi-function uterus cavity adhesion control device, comprises casing play 1, expansion inner bag 2, check valve 3, and connecting duct 4, Pressure gauge 5, administrator 6, pressure injector 7,
Described casing play 1 is shaped as bionical uterus structure, the anti-expansion of material selection, the soft good silica gel material of biocompatibility are made, administration channel 10 is offered at the position that is easy to stick together, its surface, can directly prevent the composition of medicine of intrauterine adhesion by these administration channels; Described casing play 1 has the first opening, and described the first opening is connected with described check valve; Described administration channel is 10～50, and its diameter is 0.5mm～3mm.
Described expansion inner bag 2, is the latex material of good expansion character and comprcssive strength, and it is arranged on described casing play 1 inner side, has the second opening, and described the second opening is connected with described check valve; The first opening and the second opening meet form two-chamber passage, and described two-chamber passage is communicated with respectively cavity between expansion inner bag 2 and described casing play 1 and the cavity in expansion inner bag 2, and first and second open end all connects check valve.
Described check valve 3 has the first valve port 31 and the second valve port 32, and described the first valve port 31 is communicated with the cavity 8 between described casing play 1 with described expansion inner bag 2; Described the second valve port 32 is communicated with the cavity 9 in described expansion inner bag;
Described connecting duct 4 comprises the first connecting duct 41 and the second connecting duct 42, one end of described the first connecting duct 41 and the second connecting duct 42 all removably connects with described check valve 3, described the first connecting duct is communicated with the cavity between described casing play 1 with described expansion inner bag 2 by described check valve, and described the second connection tube is communicated with the cavity in described expansion inner bag 2 by described check valve 3;
Described Pressure gauge 5 is arranged on described the second connecting duct and with it and is communicated with; Described administrator 6 removably connects with described first connecting duct 41 other ends; Described pressure injector 7 and second connecting duct 42 other ends removably connect.
Casing play 1 is shaped as bionical uterus structure, its at Jiao,Gong edge, palace, palace top and cervix uteri etc. easily stick together out administration channel are set, and can better discharge medicine, prevent that adhesion from occurring.
The external inner-rotary type interface of the preferred described check valve 3 of this utility model.The built-in spring top stop type of described check valve 3 valve.As shown in Figure 2, also comprise thimble 11, described thimble, for jack-up administration check valve, discharges the medicinal liquid of the cavity between described expansion inner bag 2 and described casing play 1 and the liquid in the cavity in described expansion inner bag 2.
After a kind of multi-function uterus cavity adhesion control of this utility model device is performed the operation for uteroventral operation, uterine cavity is carried out to the utensil of integrated management use, its process is: postoperative, this intrauterine adhesion control device is selected to suitable model (structure of this device can be made large, medium and small three kinds of models according to the size and dimension of cavity of uterus) insert core uterine cavity according to uterus size, then by connecting administrator, by the first connecting pipe 41, by the first valve port on check valve 3, inject combined therapy medicine and material, administration recession is except administrator; Then by the second connecting pipe 42 Bonding pressure tables 5 and pressure injector 7, inject water for injection or normal saline, the inner bag 2 that makes to expand expands, capsula interna makes casing play swell compressing Uterus wall after expanding, realize hemostasis by compression, when realizing hemostasis by compression, the administration channel that the anti-adhesion gel material in the cavity between expansion inner bag 2 and described casing play 1 and medicine arrange by casing play surface continues to be distributed to endometrial surface and realizes lasting therapeutical effect.Its pressure is adjustable, and the administration cycle can repetitive operation, until cure completely.
At drug effect week after date, can pass through thimble, jack-up check valve, discharges transudate, then discharges and inlays the liquid in inner bag expanding layer.Complete a connecting duct in dismountable this device of administration week after date, its casing play and expansion inner bag, check valve can be retained in cavity of uterus, lasting performance isolation, administration effect.The action that needs to repeat administration and discharge transudate according to treatment, until uterine cavity wound healing.
The foregoing is only preferred embodiment of the present utility model, not in order to limit this utility model, all within spirit of the present utility model and principle, any modification of doing, be equal to replacement, improvement etc., within all should being included in protection domain of the present utility model.
Claims (9)
1. a multi-function uterus cavity adhesion control device, is characterized in that, comprises casing play (1), expansion inner bag (2), check valve (3), and connecting duct (4), Pressure gauge (5), administrator (6), pressure injector (7),
Described casing play (1) is shaped as bionical uterus structure, is provided with a plurality of administration channels (10) and has the first opening on it, and described the first opening is connected with described check valve;
Described expansion inner bag (2) is arranged on described casing play (1) inner side, has the second opening, and described the second opening is connected with described check valve;
Described check valve (3) has the first valve port (31) and the second valve port (32), and described the first opening is communicated with the cavity (8) between described casing play (1) with described expansion inner bag (2) by described the first valve port (31); Described the second opening is communicated with the cavity (9) in described expansion inner bag by described the second valve port (32);
Described connecting duct (4) comprises the first connecting duct (41) and the second connecting duct (42), all (3 removably connect with described check valve in one end of described the first connecting duct (41) and the second connecting duct (42), described the first connecting duct (41) is communicated with the cavity (8) between described casing play (1) with described expansion inner bag (2) by described check valve (3), and described the second connection tube (42) is communicated with the cavity (9) in described expansion inner bag (2) by described check valve (3);
Described Pressure gauge (5) is arranged on described the second connecting duct and with it and is communicated with; Described administrator (6) removably connects with described the first connecting duct (41) other end; Described pressure injector (7) removably connects with the second connecting duct (42) other end.
2. a kind of multi-function uterus cavity adhesion prevents and treats device according to claim 1, it is characterized in that, described administrator (6) is the syringe of Rule conehead.
3. according to a kind of multi-function uterus cavity adhesion control device described in claim 1 or 2, it is characterized in that, described administration channel (10) is 10～50, and its diameter is 0.5mm～3mm.
4. a kind of multi-function uterus cavity adhesion prevents and treats device according to claim 1, it is characterized in that, described administration channel (10) is arranged on a place or any a few place of Jiao,Gong edge, palace, top, palace and the cervix uteri of casing play.
5. according to a kind of multi-function uterus cavity adhesion control device described in claim 1 or 2 or 4, it is characterized in that, casing play (1) is silica gel material.
6. according to a kind of multi-function uterus cavity adhesion control device described in claim 1 or 2 or 4, it is characterized in that, described expansion inner bag (2) is latex material.
7. according to a kind of multi-function uterus cavity adhesion control device described in claim 1 or 2 or 4, it is characterized in that the external inner-rotary type interface of described check valve (3).
8. according to a kind of multi-function uterus cavity adhesion control device described in claim 1 or 2 or 4, it is characterized in that the built-in spring top stop type of described check valve (3) valve.
9. a kind of multi-function uterus cavity adhesion prevents and treats device according to claim 1, it is characterized in that, also comprise thimble, described thimble, for jack-up administration check valve, discharges the medicinal liquid of the cavity between described expansion inner bag (2) and described casing play (1) and the liquid in the cavity in described expansion inner bag (2).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201320636158.9U CN203468711U (en) | 2013-10-15 | 2013-10-15 | Multifunctional intrauterine adhesion control and treatment unit |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201320636158.9U CN203468711U (en) | 2013-10-15 | 2013-10-15 | Multifunctional intrauterine adhesion control and treatment unit |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN203468711U true CN203468711U (en) | 2014-03-12 |
Family
ID=50217141
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201320636158.9U Expired - Lifetime CN203468711U (en) | 2013-10-15 | 2013-10-15 | Multifunctional intrauterine adhesion control and treatment unit |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN203468711U (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104434277A (en) * | 2014-11-13 | 2015-03-25 | 段华 | Uterus-shaped anti-adhesion screen device and application method thereof |
| CN105268090A (en) * | 2015-09-01 | 2016-01-27 | 北京中科盛康科技有限公司 | Medicine application device for controlling intrauterine adhesion |
| CN110974521A (en) * | 2019-11-25 | 2020-04-10 | 华中科技大学同济医学院附属协和医院 | 3D printing model for preventing uterine cavity from being sticky and manufacturing method |
| CN113367757A (en) * | 2020-03-10 | 2021-09-10 | 李美英 | Uterus hemostasis sacculus |
| EP3878385A4 (en) * | 2018-11-08 | 2022-08-31 | Alonso Pacheco, Luis | Intrauterine expander device |
-
2013
- 2013-10-15 CN CN201320636158.9U patent/CN203468711U/en not_active Expired - Lifetime
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104434277A (en) * | 2014-11-13 | 2015-03-25 | 段华 | Uterus-shaped anti-adhesion screen device and application method thereof |
| CN105268090A (en) * | 2015-09-01 | 2016-01-27 | 北京中科盛康科技有限公司 | Medicine application device for controlling intrauterine adhesion |
| EP3878385A4 (en) * | 2018-11-08 | 2022-08-31 | Alonso Pacheco, Luis | Intrauterine expander device |
| CN110974521A (en) * | 2019-11-25 | 2020-04-10 | 华中科技大学同济医学院附属协和医院 | 3D printing model for preventing uterine cavity from being sticky and manufacturing method |
| CN110974521B (en) * | 2019-11-25 | 2024-01-02 | 华中科技大学同济医学院附属协和医院 | 3D printing model for preventing uterine cavity from sticking and manufacturing method |
| CN113367757A (en) * | 2020-03-10 | 2021-09-10 | 李美英 | Uterus hemostasis sacculus |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN203468711U (en) | Multifunctional intrauterine adhesion control and treatment unit | |
| CN202776442U (en) | Packing device for treating uterine bleeding | |
| CN102657546B (en) | Carrier barrier system applied to prevention and treatment of metrosynizesis | |
| CN103417272B (en) | A kind of medicine distribution type uterus support | |
| CN101657172A (en) | The method and apparatus that is used for inaccessible lumen | |
| CN203710445U (en) | Indwelling cleaning drug delivery device for department of gynecology and obstetrics | |
| CN202637025U (en) | Sacculus uterine support | |
| CN105708514A (en) | Device for uterus hemostasis | |
| CN108652699A (en) | A kind of novel gynecological hemostasis device | |
| CN205612515U (en) | Be used for hemostatic device in uterus | |
| CN202859897U (en) | Cervical conformal packing and injecting device | |
| CN206508369U (en) | One uterine cryptomere support tube | |
| CN201131825Y (en) | Vagina shaping dilator | |
| CN203139357U (en) | Gynecological triple-bag multi-cavity tube | |
| CN102657913A (en) | Cervical conformal packing injection device | |
| CN203539420U (en) | Medicine-distribution type uterus stent | |
| CN106166324A (en) | A kind of biocompatibility dilator | |
| CN103055408B (en) | Gynecological three capsule multi-lumen tube | |
| CN205514753U (en) | Delivery aid device for gynaecology and obstetrics | |
| CN204073050U (en) | Sacculus uterus support | |
| CN204600577U (en) | Uterine cavity compressing sacculus and the triple channel for uterine cavity compressing sacculus | |
| CN205569008U (en) | Gynaecology and obstetrics's hemostasis bag | |
| CN106491175A (en) | Sexual oppression uterine cavity hemostasis administration capsule band | |
| CN208942492U (en) | A kind of vagina balloon-stent | |
| CN206239879U (en) | Encysted rectum type constipation treating instrument |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CX01 | Expiry of patent term |
Granted publication date: 20140312 |
|
| CX01 | Expiry of patent term |